Independent and cooperative action of Psen2 with Psen1 in zebrafish embryos

被引:42
|
作者
Nornes, Svonhild [1 ]
Newman, Morgan [1 ]
Wells, Simon [1 ]
Verdile, Giuseppe [2 ]
Martins, Ralph N. [2 ]
Lardelli, Michael [1 ]
机构
[1] Univ Adelaide, Sch Mol & Biomed Sci, Discipline Genet, Adelaide, SA 5005, Australia
[2] Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Ctr Excellence Alzheimers Dis Res & Care, Joondalup, WA 6027, Australia
基金
英国医学研究理事会;
关键词
Presenilin; Notch; gamma-secretase; Zebrafish; DoLA neurons; Melanocyte; ALZHEIMERS-DISEASE; NEURAL CREST; KUPFFERS VESICLE; GENE-EXPRESSION; GAMMA-SECRETASE; BETA-CATENIN; IN-VIVO; PRESENILIN-1; APOPTOSIS; DIFFERENTIATION;
D O I
10.1016/j.yexcr.2009.06.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Presenilin1 (PSEN1) and presenilin2 (PSEN2) are involved in the processing of type-l transmembrane proteins including the amyloid precursor protein (APP), Notch and several others. PSEN1 has been shown to be crucial for proteolytic cleavage of Notch in developing animal embryos. Mouse embryos lacking Psen1 function show disturbed neurogenesis and somite formation. resembling Notch pathway mutants. However, loss of Psen2 activity reveals only a minor phenotype. Zebrafish embryos are a valuable tool for analysis of the molecular genetic control of cell differentiation since endogenous gene expression call be modulated ill Subtle and complex ways to give a phenotypic readout. Using injection of morpholino antisense oligonucleotides to inhibit protein translation in zebrafish embryos, we show that reduced Psen2 activity decreases the number of melanocytes in the trunk but not in the Cranial area at 2 days post fertilisation (dpf). Reduced Psen2 activity apparently reduces Notch signalling resulting in perturbed spinal neurogenin1 (neurog1) expression, nenrogenesis and trunk and tail neural crest development. Similar effects are seen for reduced Psen1 activity. These results suggest that Psen2 plays a more prominent role in Notch signalling and embryo development in zebrafish than in mammals. Intriguingly, decreased Psen2 activity increases the number of Dorsal Longitudinal Ascending (DoLA) interneurons in the spinal cord while decreased Psen1 activity has no effect. However, the effect on Dol-As of reduced Psen2 can be ameliorated by Psen1 loss. The effects of changes in Psen2 activity on Dol-A interneurons and other cells in zebrafish embryos provide bioassays for more detailed dissection of Psen2 function. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:2791 / 2801
页数:11
相关论文
共 50 条
  • [41] Neuropathology of the Jalisco A431E PSEN1 Mutation in Comparison to Other PSEN1 Mutations in Autosomal Dominant Alzheimer's Disease
    Estrella, M.
    Hird, K.
    Goodwill, V.
    Pizzo, D.
    Galasko, D.
    Gopal, P.
    Guzman, S.
    Hawes, D.
    Ringman, J.
    Church, C.
    Hiniker, A.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 575 - 575
  • [42] Dementia associated with the PSEN2 R71Wvariant
    Ghetti, Bernardino
    Oblak, Adrian
    Richardson, Rose
    Epperson, Francine
    Garringer, Holly
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2016, 75 (06): : 573 - 573
  • [43] Quantitative neuropathological comparisons between Down Syndrome and PSEN2
    Latimer, C.
    Postupna, N.
    Ariza-Torres, J.
    Pacleb, M.
    Damodarasamy, M.
    Wilson, A.
    Jayadev, S.
    Thomas, B.
    Keene, C.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 492 - 492
  • [44] PSEN1 and Nup98 as Diagnostic Biomarkers for Myocarditis
    Hanson, Paul J.
    Cheng, Li
    Rai, Harpreet
    Jang, Erika L.
    McManus, Bruce
    Seidman, Michael
    LABORATORY INVESTIGATION, 2018, 98 : 124 - 124
  • [45] Characterization of spastic paraplegia in a family with a novel PSEN1 mutation
    Ringman, John M.
    Dorrani, Naghmeh
    Fernandez, Sara Gutierrez
    Signer, Rebecca
    Martinez-Agosto, Julian
    Lee, Hane
    Douine, Emilie D.
    Qiao, Yuchuan
    Shi, Yonggang
    D'Orazio, Lina
    Pawar, Sanjay
    Robbie, Leah
    Kashani, Amir H.
    Singer, Maxwell
    Byers, Joshua T.
    Magaki, Shino
    Guzman, Sam
    Sagare, Abhay
    Zlokovic, Berislav
    Cederbaum, Stephen
    Nelson, Stanley
    Sheikh-Bahaei, Nasim
    Chui, Helena C.
    Chavez-Gutierrez, Lucia
    Vinters, Harry V.
    BRAIN COMMUNICATIONS, 2023, 5 (02)
  • [46] PSEN1 and Nup98 as Diagnostic Biomarkers for Myocarditis
    Hanson, Paul J.
    Cheng, Li
    Rai, Harpreet
    Jang, Erika L.
    McManus, Bruce
    Seidman, Michael
    MODERN PATHOLOGY, 2018, 31 : 124 - 124
  • [47] Evolving brain structural changes in PSEN1 mutation carriers
    Sala-Llonch, Roser
    Llado, Albert
    Fortea, Juan
    Bosch, Beatriz
    Antonell, Anna
    Balasa, Mircea
    Bargallo, Nuria
    Bartres-Faz, David
    Luis Molinuevo, Jose
    Sanchez-Valle, Raquel
    NEUROBIOLOGY OF AGING, 2015, 36 (03) : 1261 - 1270
  • [48] Selective inhibitors of the PSEN1–gamma-secretase complex
    Serneels L.
    Narlawar R.
    Perez-Benito L.
    Municoy M.
    Guallar V.
    T'Syen D.
    Dewilde M.
    Bischoff F.
    Fraiponts E.
    Tresadern G.
    Roevens P.W.M.
    Gijsen H.J.M.
    De Strooper B.
    Journal of Biological Chemistry, 2023, 299 (06)
  • [49] High resolution haplotype analysis of the PSEN1 gene.
    Yamagata, H
    Matsubara-Tsutsui, M
    Kamino, K
    Nakura, J
    Morishima, A
    Mitsuda, N
    Kondo, I
    Miki, T
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 471 - 471
  • [50] Clinical and Neuropathologic Heterogeneity in PSEN1 A431E
    Murrell, Jill
    Mehta, Rupal
    Bigio, Eileen
    Cairns, Nigel
    Cochran, Elizabeth
    Gitelman, Darren
    Head, Elizabeth
    Leverenz, James
    Poon, Wayne
    Takao, Masaki
    Weintraub, Sandra
    Ringman, John
    Ghetti, Bernardino
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2012, 71 (06): : 562 - 563